Status
Conditions
Treatments
About
The purpose of this study is to determine whether treatment by the miraDry System can safely reduce the severity of axillary hyperhidrosis (excessive underarm sweating).
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Subject is 18 years of age or older at the time of consent.
Subject reports a quality-of-life rating of 3 or 4 on the Hyperhidrosis Disease Severity Scale.
Subject has a baseline gravimetric measurement of spontaneous resting sweat production of at least 50mg/5min at room temperature in each axilla.
Subject has primary focal axillary hyperhidrosis evidenced by at least two of the following:
In the opinion of the physician, treatment with the miraDry System is technically feasible and clinically indicated.
Subject has provided written informed consent using a form that has been approved by the reviewing IRB/ethics committee.
Subject is willing and able to comply with protocol requirements and all study visits.
Female subjects of child-bearing potential must not be pregnant or lactating and must agree to not become pregnant during the course of the study.
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
31 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal